Prenetics Global Ltd has reported impressive financial results for the third quarter of 2026, demonstrating a remarkable 266% year-over-year revenue growth. The company’s performance not only surpassed its own revenue guidance but also highlighted its expanding market presence in the pharmaceutical preparations industry.

On November 18, 2026, Prenetics released its unaudited financial results for the quarter ending September 30, 2026. The company reported total revenues of $64.1 million, significantly exceeding its forecast of $63 million to $64 million. This growth is primarily attributed to the success of its direct-to-consumer wellness brand, IM8, which generated $62.9 million in revenue for the quarter.

Background

Prenetics Global Ltd, incorporated in Hong Kong, operates in the pharmaceutical preparations sector (SIC 2834) and trades on the Nasdaq under the ticker symbols PRE and PRENW. The company has been recognized for its innovative approach to health and wellness, particularly through its AI-driven product offerings. Recent filings indicate a strong trajectory for the company, with several reports submitted in November 2026 alone.

What the Filing Says

The recent filing includes a press release detailing the financial results, which states, "Total revenue of $64.1 million, up approximately 228% YoY; above the Company’s guidance of $63-64 million." Additionally, the report highlights that September 2026 was the strongest month ever for IM8, with $23.7 million in revenue.

Impact

This financial success may significantly affect various stakeholders, including investors, potential customers, and competitors in the pharmaceutical preparations space. The company's ability to attract and retain customers is underscored by the fact that its initial customer base has returned over 4.1 times their acquisition cost in gross profit within two years.

What's Next

Prenetics has reaffirmed its revenue guidance for fiscal year 2026, expecting total revenue between $220 million and $230 million, alongside a projected revenue of over $400 million for FY 2027. The filing does not specify any immediate next steps beyond these projections, but the company is likely to continue its investment in customer acquisition and product development.